This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: National Institute of Health and Medical Research, Bayer Pharma Aktiengesellschaft, Lfb Biotechnologies. Active years: 2009-2014.
Company Filing History:
2 out of 1,853 
1 out of 386 
1 out of 10 Years Active: 2009-2014
Title: Innovations of Srinivas Kaveri
Introduction
Srinivas Kaveri is a notable inventor based in Malakoff, France. He has made significant contributions to the field of biotechnology, particularly in the treatment of hemophilia A. With a total of 2 patents, his work focuses on improving therapeutic options for patients suffering from this condition.
Latest Patents
Kaveri's latest patents include groundbreaking inventions aimed at enhancing the efficacy of Factor VIII treatments. One of his patents, titled "Demannosylated recombinant factor VIII for the treatment of patients with haemophilia A," presents a modified Factor VIII with substantially decreased immunogenicity in humans. This innovation is crucial for hemophiliacs, as it helps to avoid or prevent the action of inhibitory anti-FVIII antibodies. Another significant patent is related to "Catalytic anti-factor VIII allo-antibodies," which discloses a method for determining the presence of these antibodies capable of degrading Factor VIII in mammals. This invention also includes a pharmaceutical composition that can inhibit the degradation of Factor VIII, providing a promising therapeutic avenue for patients.
Career Highlights
Throughout his career, Srinivas Kaveri has worked with esteemed organizations such as the National Institute of Health and Medical Research and LFB Biotechnologies. His experience in these institutions has allowed him to develop and refine his innovative approaches to biotechnology.
Collaborations
Kaveri has collaborated with notable colleagues, including Sébastien Lacroix-Desmazes and Suryasarathi Dasgupta. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Srinivas Kaveri's contributions to biotechnology, particularly in the treatment of hemophilia A, highlight his role as an influential inventor. His innovative patents and collaborations reflect his commitment to improving patient care through scientific advancements.